A steady stream of headlines makes it obvious. The incomprehensibility of a chronic disease like obesity is overwhelming. The New York Times tells us it’s a hard truth about obesity medicines: “You’ll probably need them forever.” The wellness industry is peddling dubious strategies for an “off-ramp” from GLP-1 therapies with inflated claims about “sustained remission.” […]

